These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 7778535)

  • 1. Angiotensin-converting enzyme inhibitors in the clinical setting of chronic congestive heart failure.
    Reyes AJ
    Am J Cardiol; 1995 Jun; 75(18):50F-55F. PubMed ID: 7778535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fundamental role of angiotensin-converting enzyme inhibitors in the management of congestive heart failure.
    Opie LH
    Am J Cardiol; 1995 Jun; 75(18):3F-6F. PubMed ID: 7778532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinctive properties of perindopril among converting enzyme inhibitors in congestive heart failure.
    Sami MH
    Can J Cardiol; 1994 Nov; 10 Suppl D():13D-16D. PubMed ID: 7954033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACE inhibitors in congestive heart failure.
    Kantner TR
    J Fam Pract; 1992 Sep; 35(3):305-14. PubMed ID: 1517728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Twice-daily administration of a long-acting angiotensin-converting enzyme inhibitor has greater effects on neurohumoral factors than a once-daily regimen in patients with chronic congestive heart failure.
    Hirooka K; Koretsune Y; Yoshimoto S; Irino H; Abe H; Yasuoka Y; Yamamoto H; Hashimoto K; Chin W; Kusuoka H
    J Cardiovasc Pharmacol; 2004 Jan; 43(1):56-60. PubMed ID: 14668568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of angiotensin-converting enzyme inhibitors in congestive heart failure.
    Galvao M
    Heart Lung; 1990 Sep; 19(5 Pt 1):505-11. PubMed ID: 2211159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACE inhibitors in the treatment of heart failure.
    DiBianco R
    Clin Cardiol; 1990 Jun; 13(6 Suppl 7):VII32-8. PubMed ID: 2189619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gradual reactivation over time of vascular tissue angiotensin I to angiotensin II conversion during chronic lisinopril therapy in chronic heart failure.
    Farquharson CA; Struthers AD
    J Am Coll Cardiol; 2002 Mar; 39(5):767-75. PubMed ID: 11869839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Underutilisation of ACE inhibitors in patients with congestive heart failure.
    Bungard TJ; McAlister FA; Johnson JA; Tsuyuki RT
    Drugs; 2001; 61(14):2021-33. PubMed ID: 11735631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacologic treatment of chronic congestive heart failure].
    Halawa B
    Przegl Lek; 1996; 53(3):119-23. PubMed ID: 8754362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congestive heart failure: what should be the initial therapy and why?
    Chatterjee K
    Am J Cardiovasc Drugs; 2002; 2(1):1-6. PubMed ID: 14727993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial.
    Granger CB; McMurray JJ; Yusuf S; Held P; Michelson EL; Olofsson B; Ostergren J; Pfeffer MA; Swedberg K;
    Lancet; 2003 Sep; 362(9386):772-6. PubMed ID: 13678870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-converting enzyme inhibitors in congestive heart failure.
    Deedwania PC
    Arch Intern Med; 1990 Sep; 150(9):1798-805. PubMed ID: 2132302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Community pharmacist outreach program directed at physicians treating congestive heart failure.
    Turner CJ; Parfrey P; Ryan K; Miller R; Brown A
    Am J Health Syst Pharm; 2000 Apr; 57(8):747-52. PubMed ID: 10786260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is the role of angiotensin-converting enzyme inhibitors in congestive heart failure and after myocardial infarction?
    Nelson KM; Yeager BF
    Ann Pharmacother; 1996 Sep; 30(9):986-93. PubMed ID: 8876861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic drug interactions with ACE inhibitors.
    Shionoiri H
    Clin Pharmacokinet; 1993 Jul; 25(1):20-58. PubMed ID: 8354016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How often are angiotensin II and aldosterone concentrations raised during chronic ACE inhibitor treatment in cardiac failure?
    MacFadyen RJ; Lee AF; Morton JJ; Pringle SD; Struthers AD
    Heart; 1999 Jul; 82(1):57-61. PubMed ID: 10377310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A survey of current use of angiotensin-converting-enzyme inhibitors by Scottish physicians in the treatment of chronic cardiac failure.
    McMurray J; Lang CC; Maclean DD; McDevitt DG; Struthers AD
    Scott Med J; 1989 Apr; 34(2):425-7. PubMed ID: 2740888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin antagonism in patients with heart failure: ACE inhibitors, angiotensin receptor antagonists or both?
    Cruden NL; Newby DE
    Am J Cardiovasc Drugs; 2004; 4(6):345-53. PubMed ID: 15554719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.